Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

SHE:301166 Revenue

Shanghai Universal Biotech had revenue of 347.01M CNY in the quarter ending September 30, 2026, with 27.94% growth. This brings the company's total for the last twelve months to 1.22B, up 14.74% year-over-year. In the year 2025, Shanghai Universal Biotech had annual revenue of 1.08B, down -3.05%. That makes Shanghai Universal Biotech the 18,102nd largest company in the world by revenue and 3,306th in China.

• Revenue (ttm): 1.22B
• Revenue Growth: +14.74%
• P/S Ratio: 2.09
• Revenue / Employee: 1.51M
• Employees: 832
• Market Cap: 2.56B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.08B 99.5%
• Overseas 5.21M 0.5%

Fiscal year ended Dec 31, 2025 See the full SHE:301166 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.08B	-34.05M	-3.05%
Dec 31, 2024	1.12B	-108.07M	-8.82%
Dec 31, 2023	1.23B	30.70M	2.57%
Jan 1, 2023	1.20B	85.46M	7.70%
Jan 1, 2022	1.11B	260.59M	30.69%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error